Method for measuring consistency of perfusion to predict surgical outcomes
By measuring vital sign features during cardiopulmonary bypass and calculating variation metrics, the method addresses the need for assessing perfusion consistency under anesthesia to predict surgical outcomes and complications, enhancing surgical success and safety.
Patent Information
- Application Number
- PCT/US2026/026990
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-08
- Filing Date
- 2026-05-07
- Publication Date
- 2026-11-12
AI Technical Summary
There is a need for a method to measure the intra-operative and interoperative consistency of perfusion under anesthesia to understand and predict surgical outcomes, including procedure success rate and complications.
A method involving the measurement of vital sign features during cardiopulmonary bypass at multiple timepoints, calculation of standard deviation and mean for each feature, and determination of coefficient of variation to assess intra- and interoperative perfusion consistency, aligning surgeries with standard of care and general practices.
The method provides insights into surgical outcomes by identifying fluctuations in vital signs, predicting complications like acute kidney injury, and ensuring adherence to clinical standards, thereby improving patient safety and surgical success.
Smart Images

Figure 00000010_0000
Abstract
Description
METHOD FOR MEASURING CONSISTENCY OFPERFUSION TO PREDICT SURGICAL OUTCOMESRELATED APPLICATIONS
[0001] This application claims priority benefit of U.S. Provisional Application Serial Number 63 / 802.065, filed May 8, 2025, the contents of which are hereby incorporated by reference.FIELD OF THE INVENTION
[0002] The present invention relates generally to a method for measuring intra-operative and interoperative consistency of perfusion while under anesthesia, and in particular to a method for measuring intra-operative and interoperative consistency of perfusion while under anesthesia in order to understand and predict surgical outcomes, including procedure success rate and complications.BACKGROUND OF THE INVENTION
[0003] In the context of anesthesia, perfusion refers to the delivery of oxygen and nutrients to tissues via the blood, and the removal of waste products. Anesthesia can impact perfusion in several ways, and understanding these effects is crucial for patient safety and well-being.
[0004] Thus, there exists a need for a method for measuring intra-operative and interoperative consistency of perfusion while under anesthesia in order to understand and predict surgical outcomes, including procedure success rate and complications.SUMMARY OF THE INVENTION
[0005] The present invention provides a method for measuring consistency of perfusion during a surgical procedure in order to understand and predict surgical outcomes, including procedure success rate and complications. The method includes measuring a plurality of vital sign features during a cardiopulmonary bypass period of the surgical procedure at a plurality of timepoints; calculating a standard deviation for each of the plurality of vital sign features measured; calculating a mean for each of the plurality of vital sign features measured; and calculating a coefficient of variation for each of the plurality of vital sign features measured by dividing the standard deviation for each of the plurality of vital sign features measured by the mean for each of the plurality of vital sign features measured. The method additionally includes calculating an interoperative consistency of perfusion to determine whether the surgical procedure aligns with a standard of care within a hospital or whether the surgical procedure complies with general standard practices.BRIEF DESCRIPTION OF THE DRAWINGS
[0006] The present invention is further detailed with respect to the following figures that depict various aspects of the present invention.
[0007] FIG. 1 is a plot showing DO2i CORE consistency during CPB measured with the coefficient of variation in relation to severe AKI.DESCRIPTION OF THE INVENTION
[0008] The present invention has utility as a method for measuring intra-operative and interoperative consistency of perfusion while under anesthesia in order to understand and predict surgical outcomes, including procedure success rate and complications.
[0009] The present invention will now be described with reference to the following embodiments. As is apparent by these descriptions, this invention can be embodied in different forms and should not be construed as limited to the embodiments set forth herein. Rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the invention to those skilled in the art. For example, features illustrated with respect to one embodiment can be incorporated into other embodiments, and features illustrated with respect to a particular embodiment may be deleted from the embodiment. In addition, numerous variations and additions to the embodiments suggested herein will be apparent to those skilled in the art in light of the instant disclosure, which do not depart from the instant invention. Hence, the following specification is intended to illustrate some particular embodiments of the invention, and not to exhaustively specify all permutations, combinations, and variations thereof.
[0010] It is to be understood that in instances where a range of values are provided that the range is intended to encompass not only the end point values of the range but also intermediate values of the range as explicitly being included within the range and varying by the last significant figure of the range. By way of example, a recited range of from 1 to 4 is intended to include 1-2, 1-3, 2-4, 3-4, and 1-4.
[0011] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. The terminology used in the description of the invention herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention.
[0012] Unless indicated otherwise, explicitly or by context, the following terms are used herein as set forth below.
[0013] As used in the description of the invention and the appended claims, the singular forms “a,” “an” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise.
[0014] Also as used herein, “and / or” refers to and encompasses any and all possible combinations of one or more of the associated listed items, as well as the lack of combinations when interpreted in the alternative (“or”).
[0015] According to embodiments, a method for measuring intra-operative and interoperative consistency of perfusion while under anesthesia is provided in order to understand and predict surgical outcomes, including procedure success rate and complications. According to embodiments the inventive method determines the CORE measure, which encompasses the consistency of perfusion both during surgery (intra-operative consistency) and between surgeries (interoperative consistency) for features on which perfusionists have direct impact. The intraoperative CORE measure reflects how much variation there is for vital signs during the surgery, displaying a measure of how well the perfusionist can stabilize that single patient. On the other hand, the inter-operative CORE measure reflects whether the standard of care is stable between different surgeries and perfusionists within a hospital. It also displays whether hospitals comply with guidelines. The measures can aid perfusionists and hospital directors to increase their understanding of their standard of care.
[0016] According to embodiments, the CORE measure is expanded to include best practice and application of the CORE measure to other medical specialties, not only surgery. The CORE measure is also able to be controlled for important patient characteristics, such as diabetes and kidney disease.
[0017] To assess clinical relevance of the intra- and interoperative CORE Consistency measures, the correlation between the measures and post-cardiac surgery outcomes are assessed, including procedure success rate and complications such as acute kidney injury (AKI).
[0018] According to embodiments, intra-operative CORE consistency is established by looking at the fluctuation of vital signs and by detecting outliers within the cardiopulmonary bypass (CPB) period. Each vital sign is assessed separately. The features used for the intraoperative CORE Consistency are measured and computed vital signs or otherwise features descriptive of the bodily state, which are assessed at regular intervals during the surgery. These vital signs include Hemoglobin / Hematocrit, DO2i, Cardiac index, and Mean Arterial Pressure.
[0019] According to embodiments, fluctuation is measured using the coefficient of variation (CV), for which the computation is shown in Equation 1. To get the CPB CV, the standard deviation and mean of the whole CPB period is computed.
[0020] Equation 1:Standard DeviationCoefficient of Variation = - Mean
[0021] Each vital sign is assessed throughout the whole surgery, each timepoint is evaluated whether it is consistent in the surgery or not. Outliers are defined based on the absolute deviation from the median. Each timepoint is separately scored as being an outlier or not.
[0022] The coefficient of variation for each monitored vital sign provides insight into surgical outcomes, including procedure success rate and complications. For example, a relation has been found between the DO2i coefficient of variation during both the CPB and cross-clamp period and post-operative severe AKI rates, as shown in FIG. 1. A higher coefficient of variation during CPB corresponds with more fluctuations in the vital sign. The relation found between the DO2i CV andsevere AKI shows that more fluctuation during CPB is an indicator of developing severe AKI in the first 48 hours after surgery.
[0023] According to embodiments, the computation of the intra-operative fluctuation is expanded with other measures of variation. Additionally, computing the CV for specific shorter periods within the surgery can improve the Intra-operative CORE measure. According to embodiments, the intraoperative Core Consistency measure is corrected for variables including procedure type (common vs. non-common procedure), procedure urgency (elective vs. non-elective), age group, etc. Additionally, glucose can be corrected based on the presence of diabetes.
[0024] According to embodiments, the Interoperative CORE consistency is defined in two ways. First, does the surgery align with the standard of care within the hospital, and second, does the surgery comply with general standard practices. To determine the Interoperative CORE consistency, every surgery is assessed separately and receives a score based on their aggregate features.
[0025] All measures take the whole surgery into account, unless stated otherwise or if data is not available outside of CPB. Hemodilution features include average hemoglobin / hematocrit, hemoglobin I hematocrit at start CPB, lowest hemoglobin / hematocrit, hemoglobin / hematocrit at end CPB, and minutes hemoglobin < threshold. Oxygen delivery features include average DO2i, lowest DO2i, average cardiac index, lowest cardiac index, and minutes DO2i < 280. Mean Arterial Pressure features include average mean arterial pressure during CPB, minutes MAP < 50, minutes MAP > 80. and vascular resistance. Glucose features include average glucose, highest glucose, and minutes glucose > 180. According to embodiments, the features that are assessed are updated and expanded based on continuing research and through updates of the guidelines.
[0026] According to embodiments, each surgery is separately assessed for compliance with standards of practice, as defined in guidelines, such as the European Guidelines on cardiopulmonarybypass in adult cardiac surgery. For continuous features, it is assessed what their absolute deviation from the median is. The median is computed per hospital and per perfusionist and each surgery is assessed separately. For continuous features, fluctuation is measured using the coefficient of variation (CV), as shown in Equation 1. To get the CPB CV, the standard deviation and mean of the whole CPB period is computed. The mean and standard deviation are both computed based on hospital and perfusionists’ cases.
[0027] According to embodiments, each surgery is corrected based on the procedure type, procedure urgency, and age. All glucose related values are corrected based on the presence of diabetes.
[0028] Patent documents and publications mentioned in the specification are indicative of the levels of those skilled in the art to which the invention pertains. These documents and publications are incorporated herein by reference to the same extent as if each individual document or publication was specifically and individually incorporated herein by reference.
[0029] While at least one exemplary embodiment has been presented in the foregoing description and attached appendix, it should be appreciated that a vast number of variations exist. It should also be appreciated that the exemplary embodiment or exemplary embodiments are only examples, and are not intended to limit the scope, applicability, or configuration of the described embodiments in any way. Rather, the foregoing description and incorporated references will provide those skilled in the art with a convenient roadmap for implementing the exemplary embodiment or exemplary embodiments. It should be understood that various changes may be made in the function and arrangement of elements without departing from the scope as set forth in the appended claims and the legal equivalents thereof.
Claims
CLAIMS1. A method for measuring consistency of perfusion during a surgical procedure, the method comprising:measuring a plurality of vital sign features during a cardiopulmonary bypass period of the surgical procedure at a plurality of timepoints;calculating a standard deviation for each of the plurality of vital sign features measured; calculating a mean for each of the plurality of vital sign features measured; and calculating a coefficient of variation for each of the plurality of vital sign features measured by dividing the standard deviation for each of the plurality of vital sign features measured by the mean for each of the plurality of vital sign features measured.
2. The method of claim 1 wherein the consistency of perfusion is intra-operative consistency of perfusion.
3. The method of claim 1 wherein the plurality of vital sign features include hemoglobin I hematocrit, DO2i, cardiac index, and mean arterial pressure.
4. The method of claim 1 wherein each of the plurality of vital sign features is measured throughout an entire duration of the surgical procedure.
5. The method of any one of claims 1 to 4 further comprising calculating an overall coefficient of variation for the cardiopulmonary bypass period.
6. The method of any one of claims 1 to 4 further comprising detecting outlier measurements for each of the measured plurality of vital sign feature at each of the plurality of timepoints.
7. The method of any one of claims 1 to 4 further comprising comparing the calculated coefficient of variation for each of the plurality of vital sign features to known outcome relations.
8. The method of any one of claims 1 to 4 further comprising calculating an interoperative consistency of perfusion to determine whether the surgical procedure aligns with a standard of care within a hospital or whether the surgical procedure complies with general standard practices.
